(Q40740154)

23 September 2017

title

DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs (English)

1 reference

23 September 2017

0 references

0 references

0 references

Alexander Knorre

1

1 reference

23 September 2017

Mathias Wagner

2

1 reference

23 September 2017

Hans-Eckart Schaefer

3

1 reference

23 September 2017

William H Colledge

4

1 reference

23 September 2017

Heike L Pahl

5

1 reference

23 September 2017

publication date

1 February 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

383

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

271-282

1 reference

Integration of endoplasmic reticulum signaling in health and disease

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Generation and characterization of a delta F508 cystic fibrosis mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

The ER-overload response: activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Production of a severe cystic fibrosis mutation in mice by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Identification and characterization of an IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Identification of the cystic fibrosis gene: chromosome walking and jumping

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Degradation of CFTR by the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

Cystic fibrosis: genotypic and phenotypic variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.029

CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1165/AJRCMB.10.1.7507342

Identifiers

DOI

10.1515/BC.2002.029

1 reference

23 September 2017

1 reference